Predictive Proteomic Factors of the Response to Concomitant Radiochemotherapy in Esophageal Cancer
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The scope of the trial is to predict the early complete clinical response to exclusive
concomitant radiochemotherapy in esophageal cancer by the study of the pre- and per-
therapeutic proteomic profile.